In the latest installment of The Wire’s Company in the News feature, we are looking at Hengrui Pharma, or Jiangsu Hengrui Medicine Company, one of China’s leading pharmaceutical firms driving research and production of innovative drugs. Hengrui’s chairman is famous for taking the company from a state-owned enterprise in 1970 to a $1.5 billion IPO in 2025, but perhaps even more so for his family: His wife is the billionaire founder and CEO of Jiangsu-based Hansoh Pharma, and his daughter is
LISTEN NOW
Face-Off: U.S. vs. China returns for new season
An award-winning podcast about the world’s two superpowers, the two men in charge, and the vital issues that affect us all. Face-Off cuts through the noise for the real story, with essential historical context.
